Literature DB >> 19110017

Activity of TAR in inducible inhibition of HIV replication by foamy virus vector expressing siRNAs under the control of HIV LTR.

Jeonghae Park1, Peter E Nadeau, Ayalew Mergia.   

Abstract

In this report we describe foamy virus vectors with conditional expression of short interfering RNAs (siRNAs) in HIV infected cells. Short hairpin RNAs (shRNAs) based on two targets in the 5' end of the untranslated region and one in the rev gene flanked with 5' and 3' microRNA 30 (miR30) sequences were synthesized and placed under the control of an HIV promoter for Tat-mediated expression. HIV permissive cells were transduced with foamy virus vectors containing each hybrid shRNA expression cassette and tested for their efficacy on the inhibition of HIV replication. Effective Tat dependent expression of the shRNAs, as well as GFP placed downstream each shRNA was evident. In addition the results show inhibition of HIV replication by greater than 98%. Interestingly, transduction of cells with a vector lacking an shRNA also revealed GFP expression in the presence of Tat with similar levels of inhibition of virus replication. When the TAR region was removed from this vector there was neither reduction in virus replication nor Tat-induced GFP expression. These results suggest that TAR in the vector, which Tat interacts to promote expression of the shRNA, is a potent inhibitor of virus replication. Previous studies with TAR regulated expression of antiviral genes ignore the contribution of TAR in the repression of virus replication. Interpretation of effective inhibition of HIV replication by antiviral genes located downstream of TAR while neglecting the efficacy of a potent repression by TAR is misleading.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19110017      PMCID: PMC2683472          DOI: 10.1016/j.virusres.2008.11.016

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  56 in total

1.  RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals.

Authors:  P D Zamore; T Tuschl; P A Sharp; D P Bartel
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  A species of small antisense RNA in posttranscriptional gene silencing in plants.

Authors:  A J Hamilton; D C Baulcombe
Journal:  Science       Date:  1999-10-29       Impact factor: 47.728

3.  Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.

Authors:  A Björndal; H Deng; M Jansson; J R Fiore; C Colognesi; A Karlsson; J Albert; G Scarlatti; D R Littman; E M Fenyö
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 4.  Lentiviruses as gene transfer agents for delivery to non-dividing cells.

Authors:  L Naldini
Journal:  Curr Opin Biotechnol       Date:  1998-10       Impact factor: 9.740

5.  Defective HIV-1 provirus encoding a multitarget-ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny, and protects the cells from pathogenesis.

Authors:  S Y Paik; A Banerjea; C J Chen; Z Ye; G G Harmison; M Schubert
Journal:  Hum Gene Ther       Date:  1997-06-10       Impact factor: 5.695

6.  Efficient processing of primary microRNA hairpins by Drosha requires flanking nonstructured RNA sequences.

Authors:  Yan Zeng; Bryan R Cullen
Journal:  J Biol Chem       Date:  2005-06-01       Impact factor: 5.157

7.  Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA.

Authors:  Hoshang J Unwalla; Ming-Jie Li; James D Kim; Hai Tang Li; Ali Ehsani; Jessica Alluin; John J Rossi
Journal:  Nat Biotechnol       Date:  2004-11-28       Impact factor: 54.908

8.  Macrolide- and tetracycline-adjustable siRNA-mediated gene silencing in mammalian cells using polymerase II-dependent promoter derivatives.

Authors:  Laetitia Malphettes; Martin Fussenegger
Journal:  Biotechnol Bioeng       Date:  2004-11-20       Impact factor: 4.530

9.  siRNA-mediated off-target gene silencing triggered by a 7 nt complementation.

Authors:  Xiaoyu Lin; Xiaoan Ruan; Mark G Anderson; Jeffrey A McDowell; Paul E Kroeger; Stephen W Fesik; Yu Shen
Journal:  Nucleic Acids Res       Date:  2005-08-09       Impact factor: 16.971

10.  An RNA polymerase II construct synthesizes short-hairpin RNA with a quantitative indicator and mediates highly efficient RNAi.

Authors:  Hongxia Zhou; Xu Gang Xia; Zuoshang Xu
Journal:  Nucleic Acids Res       Date:  2005-04-01       Impact factor: 16.971

View more
  9 in total

1.  A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice.

Authors:  Isaac W Boss; Peter E Nadeau; Jeffrey R Abbott; Yajie Yang; Ayalew Mergia; Rolf Renne
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

2.  Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells.

Authors:  Touraj Farazmandfar; Mohammad Reza Haghshenas; Majid Shahbazi
Journal:  Hum Gene Ther       Date:  2015-08-06       Impact factor: 5.695

3.  HIV infection upregulates caveolin 1 expression to restrict virus production.

Authors:  Shanshan Lin; Xiao Mei Wang; Peter E Nadeau; Ayalew Mergia
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

4.  Caveolin 1 inhibits HIV replication by transcriptional repression mediated through NF-κB.

Authors:  Xiao Mei Wang; Peter E Nadeau; Shanshan Lin; Jeffrey R Abbott; Ayalew Mergia
Journal:  J Virol       Date:  2011-03-23       Impact factor: 5.103

5.  The foamy virus genome remains unintegrated in the nuclei of G1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus.

Authors:  Yung-Tsun Lo; Tao Tian; Peter E Nadeau; Jeonghae Park; Ayalew Mergia
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

6.  Nanotherapeutics Using an HIV-1 Poly A and Transactivator of the HIV-1 LTR-(TAR-) Specific siRNA.

Authors:  Supriya D Mahajan; Ravikumar Aalinkeel; Jessica L Reynolds; Bindukumar Nair; Donald E Sykes; Wing-Cheung Law; Hong Ding; Earl J Bergey; Paras N Prasad; Stanley A Schwartz
Journal:  Patholog Res Int       Date:  2011-05-10

Review 7.  Foamy virus vectors for HIV gene therapy.

Authors:  Miles E Olszko; Grant D Trobridge
Journal:  Viruses       Date:  2013-10-22       Impact factor: 5.048

8.  Establishing Restricted Expression of Caveolin-1 in HIV Infected Cells and Inhibition of Virus Replication.

Authors:  Yung-Tsun Lo; Peter E Nadeau; Shanshan Lin; Ayalew Mergia
Journal:  Open Microbiol J       Date:  2014-10-31

Review 9.  Prospects for Foamy Viral Vector Anti-HIV Gene Therapy.

Authors:  Arun K Nalla; Grant D Trobridge
Journal:  Biomedicines       Date:  2016-03-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.